GB9225396D0 - Improvements in or relating to organic compounds - Google Patents

Improvements in or relating to organic compounds

Info

Publication number
GB9225396D0
GB9225396D0 GB929225396A GB9225396A GB9225396D0 GB 9225396 D0 GB9225396 D0 GB 9225396D0 GB 929225396 A GB929225396 A GB 929225396A GB 9225396 A GB9225396 A GB 9225396A GB 9225396 D0 GB9225396 D0 GB 9225396D0
Authority
GB
United Kingdom
Prior art keywords
relating
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB929225396A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Priority to GB929225396A priority Critical patent/GB9225396D0/en
Publication of GB9225396D0 publication Critical patent/GB9225396D0/en
Priority to EP93810835A priority patent/EP0606044A1/en
Priority to FI935409A priority patent/FI935409A7/fi
Priority to SK1354-93A priority patent/SK135493A3/sk
Priority to MX9307608A priority patent/MX9307608A/es
Priority to AU52112/93A priority patent/AU5211293A/en
Priority to CZ932614A priority patent/CZ261493A3/cs
Priority to IL10783893A priority patent/IL107838A0/xx
Priority to NZ250344A priority patent/NZ250344A/en
Priority to PL93301281A priority patent/PL301281A1/xx
Priority to NO934372A priority patent/NO934372L/no
Priority to CA002110553A priority patent/CA2110553A1/en
Priority to CN93120777A priority patent/CN1095417A/zh
Priority to KR1019930026567A priority patent/KR940014377A/ko
Priority to ZA939088A priority patent/ZA939088B/xx
Priority to JP5303866A priority patent/JPH06228122A/ja
Priority to HU9303444A priority patent/HUT65910A/hu
Priority to TW082110279A priority patent/TW258736B/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungi isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/08—Oxygen as only ring hetero atoms containing a hetero ring of at least seven ring members, e.g. zearalenone, macrolide aglycons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Botany (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
GB929225396A 1992-12-04 1992-12-04 Improvements in or relating to organic compounds Pending GB9225396D0 (en)

Priority Applications (18)

Application Number Priority Date Filing Date Title
GB929225396A GB9225396D0 (en) 1992-12-04 1992-12-04 Improvements in or relating to organic compounds
EP93810835A EP0606044A1 (en) 1992-12-04 1993-11-29 Lactones compounds useful as pharmaceuticals
SK1354-93A SK135493A3 (en) 1992-12-04 1993-12-02 Pharmacological effective compounds, the method of their preparation and pharmaceutical compositions, which these compounds contain
NZ250344A NZ250344A (en) 1992-12-04 1993-12-02 Zearalenone analogues, their preparation from a fungal fermentation, the fungal strain, and pharmaceutical compositions
CA002110553A CA2110553A1 (en) 1992-12-04 1993-12-02 Organic compounds
MX9307608A MX9307608A (es) 1992-12-04 1993-12-02 Inhibidores de la liberacion de la citocina y antagonistas de la il-1,procedimiento para su preparacion y composiciones farmaceuticas que loscontienen.
AU52112/93A AU5211293A (en) 1992-12-04 1993-12-02 Improvements in or relating to organic compounds
CZ932614A CZ261493A3 (en) 1992-12-04 1993-12-02 Pharmacologically active compounds, process of their preparation and pharmaceutical preparations in which they are comprised
IL10783893A IL107838A0 (en) 1992-12-04 1993-12-02 Compounds useful as cytokine release inhibitors and il-1 antagonists, their preparation and pharmaceutical compositions containing them
FI935409A FI935409A7 (fi) 1992-12-04 1993-12-02 Orgaanisiin yhdisteisiin liittyviä parannuksia
PL93301281A PL301281A1 (en) 1992-12-04 1993-12-02 Novel organic compounds, method of obtaining such novel compounds and pharmaceutical composition containing them
NO934372A NO934372L (no) 1992-12-04 1993-12-02 Nye forbindelser og farmasöytisk preparat derav
CN93120777A CN1095417A (zh) 1992-12-04 1993-12-03 有机化合物的或与之有关的改进
HU9303444A HUT65910A (en) 1992-12-04 1993-12-03 Process for preparing oxygen containing macrocyclic organic compounds
KR1019930026567A KR940014377A (ko) 1992-12-04 1993-12-03 유기 화합물
ZA939088A ZA939088B (en) 1992-12-04 1993-12-03 Organic compound
JP5303866A JPH06228122A (ja) 1992-12-04 1993-12-03 有機化合物に関する改良
TW082110279A TW258736B (enExample) 1992-12-04 1993-12-06

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929225396A GB9225396D0 (en) 1992-12-04 1992-12-04 Improvements in or relating to organic compounds

Publications (1)

Publication Number Publication Date
GB9225396D0 true GB9225396D0 (en) 1993-01-27

Family

ID=10726140

Family Applications (1)

Application Number Title Priority Date Filing Date
GB929225396A Pending GB9225396D0 (en) 1992-12-04 1992-12-04 Improvements in or relating to organic compounds

Country Status (18)

Country Link
EP (1) EP0606044A1 (enExample)
JP (1) JPH06228122A (enExample)
KR (1) KR940014377A (enExample)
CN (1) CN1095417A (enExample)
AU (1) AU5211293A (enExample)
CA (1) CA2110553A1 (enExample)
CZ (1) CZ261493A3 (enExample)
FI (1) FI935409A7 (enExample)
GB (1) GB9225396D0 (enExample)
HU (1) HUT65910A (enExample)
IL (1) IL107838A0 (enExample)
MX (1) MX9307608A (enExample)
NO (1) NO934372L (enExample)
NZ (1) NZ250344A (enExample)
PL (1) PL301281A1 (enExample)
SK (1) SK135493A3 (enExample)
TW (1) TW258736B (enExample)
ZA (1) ZA939088B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4228328C2 (de) * 1992-08-26 1999-02-11 Agie Sa Maschine und Verfahren zum funkenerosiven Drahtschneiden mit einer im Querschnitt verformten Drahtelektrode
US5795910A (en) * 1994-10-28 1998-08-18 Cor Therapeutics, Inc. Method and compositions for inhibiting protein kinases
US5731343A (en) * 1995-02-24 1998-03-24 The Scripps Research Institute Method of use of radicicol for treatment of immunopathological disorders
JP3938936B2 (ja) * 1995-04-26 2007-06-27 協和醗酵工業株式会社 ラディシコール誘導体
JP2002533389A (ja) * 1998-12-24 2002-10-08 ノーベーション ファーマシューティカルズ インコーポレーテッド ｍＲＮＡ安定性に影響する化合物およびそのための使用
EP1315732B1 (en) 2000-08-25 2006-06-07 Sloan-Kettering Institute For Cancer Research Radicicol and monocillin and their analogues and uses thereof
JP2004292315A (ja) * 2000-12-14 2004-10-21 Chugai Pharmaceut Co Ltd Ｔａｋ１阻害剤
JP2004292314A (ja) * 2000-12-14 2004-10-21 Chugai Pharmaceut Co Ltd ケラチノサイト増殖抑制剤
GB0112522D0 (en) * 2001-05-23 2001-07-11 Ici Plc Catalytic process
US7915306B2 (en) 2002-03-08 2011-03-29 Eisai Co., Ltd. Macrocyclic compounds useful as pharmaceuticals
WO2003076424A1 (en) 2002-03-08 2003-09-18 Eisai Co. Ltd. Macrocyclic compounds useful as pharmaceuticals
CN1652743A (zh) * 2002-04-17 2005-08-10 大正制药株式会社 毛发生长补剂
US20060079494A1 (en) * 2004-09-27 2006-04-13 Santi Daniel V Specific kinase inhibitors
US7601852B2 (en) 2006-05-11 2009-10-13 Kosan Biosciences Incorporated Macrocyclic kinase inhibitors
ES2670423T3 (es) 2007-07-25 2018-05-30 Eisai R&D Management Co., Ltd. Inhibidores de multicinasas para uso en el tratamiento de cáncer
JP5564431B2 (ja) 2007-10-29 2014-07-30 エーザイ・アール・アンド・ディー・マネジメント株式会社 ゼアラレノンアナログ化合物ががんを処置する能力を予測する方法
RU2478630C2 (ru) 2007-12-07 2013-04-10 ЭЙСАН Ар ЭНД Ди МЕНЕДЖМЕНТ КО., ЛТД. Промежуточные соединения и способы получения зеараленоновых макролидных аналогов
CA2740873C (en) 2008-10-17 2019-09-10 Wisconsin Alumni Research Foundation Method of making biologically active alpha-beta peptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3196019A (en) * 1964-04-06 1965-07-20 Purdue Research Foundation Anabolic and estrogenic compound and process of making

Also Published As

Publication number Publication date
NO934372D0 (no) 1993-12-02
CA2110553A1 (en) 1994-06-05
MX9307608A (es) 1995-01-31
AU5211293A (en) 1994-06-16
FI935409L (fi) 1994-06-05
NO934372L (no) 1994-06-06
JPH06228122A (ja) 1994-08-16
IL107838A0 (en) 1994-04-12
ZA939088B (en) 1995-06-05
KR940014377A (ko) 1994-07-18
CZ261493A3 (en) 1994-07-13
HU9303444D0 (en) 1994-04-28
EP0606044A1 (en) 1994-07-13
HUT65910A (en) 1994-07-28
PL301281A1 (en) 1994-06-13
FI935409A0 (fi) 1993-12-02
FI935409A7 (fi) 1994-06-05
TW258736B (enExample) 1995-10-01
NZ250344A (en) 1995-10-26
SK135493A3 (en) 1994-08-10
CN1095417A (zh) 1994-11-23

Similar Documents

Publication Publication Date Title
GB9211602D0 (en) Improvements in or relating to organic compounds
GB9206016D0 (en) Improvements in or relating to organic compounds
GB9225396D0 (en) Improvements in or relating to organic compounds
GB9203769D0 (en) Improvements in or relating to organic compounds
GB9203886D0 (en) Improvements in or relating to organic compounds
GB9205308D0 (en) Improvements in or relating to organic compounds
GB9201011D0 (en) Improvements in or relating to organic compounds
GB9212547D0 (en) Improvements in or relating to organic compounds
GB9205145D0 (en) Improvements in or relating to organic compounds
GB9204468D0 (en) Improvements in or relating to organic compounds
GB9202069D0 (en) Improvements in or relating to organic compounds
GB9202059D0 (en) Improvements in or relating to organic compounds
GB9203183D0 (en) Improvements in or relating to organic compounds
GB9200645D0 (en) Improvements in or relating to organic compounds
GB9200644D0 (en) Improvements in or relating to organic compounds
GB9200600D0 (en) Improvements in or relating to organic compounds
GB9200599D0 (en) Improvements in or relating to organic compounds
GB9200588D0 (en) Improvements in or relating to organic compounds
GB9200587D0 (en) Improvements in or relating to organic compounds
GB9203864D0 (en) Improvements in or relating to organic compounds
GB9206892D0 (en) Improvements in or relating to organic compounds
GB9204470D0 (en) Improvements in or relating to organic compounds
GB9204860D0 (en) Improvements in or relating to organic compounds
GB9203865D0 (en) Improvements in or relating to organic compounds
GB9205307D0 (en) Improvements in or relating to organic compounds